Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
792
-
Total 13F shares, excl. options
-
32,004,004
-
Shares change
-
-521,334
-
Total reported value, excl. options
-
$4,624,774,830
-
Value change
-
-$68,100,443
-
Put/Call ratio
-
137%
-
Number of buys
-
235
-
Number of sells
-
387
-
Price
-
$144.37
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2025
As of 30 Sep 2025 ISHARES TR - ISHARES BIOTECH (IBB) had 892 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 32,004,004 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, CITIGROUP INC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BNP PARIBAS FINANCIAL MARKETS, UBS Group AG, JPMORGAN CHASE & CO, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, COMMERCE BANK, and WELLS FARGO & COMPANY/MN.
This table shows 892 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.